Applications are invited for appointment on contractual basis for two post of National Consultant (IDD) under the National Iodine Deficiency Disorders Control Programme by the Nutrition & IDD Cell of the Directorate General of Health Services, Ministry of Health & Family Welfare, Govt, of India, New Delhi. The details for aforesaid post are as follows:-

About Authors:
Kapil Sharma¹*, Subhash Gupta ², Yogesh Sharma¹
1 Yaresun Pharmaceuticals Pvt. Ltd.Jaipur - 302006, Rajasthan, India.
2 Oasis test house ltd.jaipur-302006,
Rajasthan, India.

SPECTROPHOTOMETRIC SIMULTANEOUS ESTIMATION OF SPIRONOLACTONE AND TORSEMIDE IN COMBINED TABLET DOSAGE FORM USING BY MULTICOMPONENT MODE OF ANALYSIS

ABSTRACT
A method for simultaneous estimation of torsemide (TRS) and spironolactone (SPL) in combined tablet dosage form has been developed. The method employs the application of multicomponent mode of analysis. This method utilize 50 % v/v methanol in distilled water. TRS show maximum absorbance at a wavelength of 288 nm and SPL at 238 nm. Where the linearity ranges for TRS and SPL were 1-5µg/ml and 5-25 µg/ml respectively. The procedure was successfully applied for the simultaneous determination of both drugs in laboratory prepared mixture and in market available tablet dosage form. The accuracy of the method was assessed by recovery studies and was found to be 98.15±0.64 and 100.27±0.15 for TRS and SPL respectively. Results of the analysis were validated statistically so that it can be used for routine analysis of TRS and SPL in combined tablet dosage form.

About Auhtors:
NIDHI KARIA, RAKHI CHANDAK,
P.WADHWANI COLLEGE OF PHARMACY,
YAVATMAL

Abstract:
In nanotechnology, a particle is defined as a small object that behaves as a whole unit in terms of its transport and properties. It is further classified according to size: In terms of diameter, fine particles cover a range between 100 and 2500 nanometers, while ultrafine particles, on the other hand, are sized between 1 and 100 nanometers. Similarly to ultrafine particles, nanoparticles are sized between 1 and 100 nanometers. Nanoparticles may or may not exhibit size-related properties that differ significantly from those observed in fine particles or bulk materials1. Although the size of most molecules would fit into the above outline, individual molecules are usually not referred to as nanoparticles.

ANSWERS of Previous PharmaQUIZ-17:

1.C    2.B    3.C    4.C    5.C

6.C    7.D    8.C    9.A    10.D

bioCampus - a center of excellence is the training division of GVK BIO where training in Advanced bioinformatics, molecular modeling, drug discovery & design and cheminformatics skills would be imparted to professionals from related inter-disciplinary fields.

A Public Limited Company in the Business of Manufacturing & Marketing of APIs and Drug Intermediates with an Annual Turnover of about Rs.70 Crores with a significant presence in the international market.

Post: Research Associate

About Authors:
Nimisha Paharia, Ankit Mittal, Garvita Joshi
MAHAKAL INSTITUTE OF PHARMACEUTICAL STUDIES,
UJJAIN (M.P.)

ABSTRACT
The pitfalls of needle-based injections are well known. A series of discoveries led to the development of the hypodermic needle which underwent significant changes. The first air-powered needle-free injection systems were developed during the 1940s and 1950s. Needle free delivery is done conveniently both for solids and liquids. Needle-free injection systems are typically made up of three components including an Injection device, disposable needle free syringe and air cartridge. Various needle free injectors are available in the market like Biojector, vitajet, iject, cool.click etc. These formulations are designed for better acceptability and patient convenience. They offer less pain and no needle phobia. They are ideally suited to chronic injections of varying doses of insulin, proteins and monoclonal antibodies.

About Authors: NIDHI KARIA^1*, RAKHI CHANDAK¹, ARATI  RATHI²
1. P.WADHWANI COLLEGE OF PHARMACY,YAVATMAL
2. ASST PROFFESER AT SUMANDEEP DEPARMENT OF PHARMACY, VADODARA

Abstract:
Bioadhesion can be defined as the process by which a natural or a synthetic polymer can adhere to a biological substrate. When the biological substrate is a mucosal layer then the phenomena is known as mucoadhesion. The substrate possessing bioadhesive property can help in devising a delivery system capable of delivering a bioactive agent for a prolonged period of time at a specific delivery site. The current review  provides  a good insight on mucoadhesive polymers, the phenomenon of mucoadhesion and the factors which have the ability to affect the mucoadhesive properties of a polymer.

Indian Rare Earths Limited (IREL) a Public Sector Undertaking under the administrative control of the Department of Atomic Energy is the industry leader in the area of Beach Sand Minerals like Ilmenite, Rutile (Titanium ores), Zircon, Monazite, Sillimanite etc. and producer of rare earth (Lanthanides) chemicals, Thorium Nitrate etc.

JIIT has been developed as a modern world class campus, with intellectually vibrant ambience in a serene and lush green environment. The state-of-the-art campus at a total project cost of Rs. 162 cores, with a total built up area of over 69623 sq.

ANSWERS of Previous PharmaQUIZ-16:

1.B    2.D    3.B    4.C    5.D

6.D    7.A    8.C    9.A    10.C

ANSWERS of Previous PharmaQUIZ-15:

1.C    2.B    3.D    4.A    5.D

6.A    7.C    8.B    9.C    10.D

Bristol-Myers Squibb Biocon R&D Center (BBRC) is a collaboration between Bristol-Myers Squibb and Syngene International, a subsidiary of the Indian biotechnology major, Biocon. This initiative is intended to help advance Bristol-Myers Squibb's work in discovery and early drug development. The center is expanding its capabilities to clinical biomarkers, toxicology and first-in-human studies.

ANSWERS of Previous PharmaQUIZ-14:

1.C    2.A    3.B    4.B    5.C

6.A    7.B    8.A    9.D    10.C

The University Institute of Pharmaceutical Sciences of the Panjab University is a premier institution of Pharmaceutical Education and Research in the country. The institute has covered a long and glorious journey of 76 years starting from Lahore in 1944 and finally settling to the present campus in Chandigarh at the foothills of Himachal.

Biocon is a research-driven, global healthcare company with a strong matrix of capabilities along the biopharmaceutical value chain. Focusing on unmet medical needs in cancer, diabetes and inflammatory diseases, it offers novel therapies on a platform of affordable innovation.